Precision Haematological Cancer Medicine / by Tariq Mughal.

By: Mughal, Tariq [author.]Contributor(s): Taylor and FrancisMaterial type: TextTextLanguage: English Publisher: Boca Raton, FL : CRC Press, [2018]Copyright date: ©2019Edition: First editionDescription: 1 online resource (241 pages) : 193 illustrations, text file, PDFContent type: text Media type: computer Carrier type: online resourceISBN: 9781315380513Subject(s): Blood -- Cancer | Blood -- Cancer -- Treatment | Hematologic Neoplasms | Precision Medicine | MEDICAL / Oncology | MEDICAL / HematologyGenre/Form: Electronic books.Additional physical formats: Print version: : No titleDDC classification:  616.99/418 LOC classification:  RC280 | .H47Online resources: Click here to view. Also available in print format.
Contents:
Precision Medicine and Future Therapeutics. Classifications and Risk Factors. Historical Milestones. Acute Myeloid Leukaemia. Acute Lymphoblastic Leukaemia. Chronic Myeloid Leukaemia. Myeloproliferative and Related Neoplasms. Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms. Leukaemias of Mature B- and T/NK-Cells. Hodgkin Lymphoma. Non-Hodgkin Lymphoma. Plasma Cell Neoplasms. Principal Treatment-Related Side Effects. Concluding Thoughts.
Abstract: Many experts now consider genetic evaluation to be pivotal for the optimal diagnosis, classification, risk stratification, and therapeutic decision-making for persons diagnosed with blood cancer. This new text specifically focuses on the genetic alterations essential for establishing diagnosis and assesses how they might impact the precision oncology standard of care. Providing an authoritative review of the state of the art, this is essential reading for physicians, hematologists, and oncologists for optimal management of individual patients.
Tags from this library: No tags from this library for this title. Log in to add tags.
    Average rating: 0.0 (0 votes)
No physical items for this record

Includes bibliographical references and index.

Precision Medicine and Future Therapeutics. Classifications and Risk Factors. Historical Milestones. Acute Myeloid Leukaemia. Acute Lymphoblastic Leukaemia. Chronic Myeloid Leukaemia. Myeloproliferative and Related Neoplasms. Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms. Leukaemias of Mature B- and T/NK-Cells. Hodgkin Lymphoma. Non-Hodgkin Lymphoma. Plasma Cell Neoplasms. Principal Treatment-Related Side Effects. Concluding Thoughts.

Many experts now consider genetic evaluation to be pivotal for the optimal diagnosis, classification, risk stratification, and therapeutic decision-making for persons diagnosed with blood cancer. This new text specifically focuses on the genetic alterations essential for establishing diagnosis and assesses how they might impact the precision oncology standard of care. Providing an authoritative review of the state of the art, this is essential reading for physicians, hematologists, and oncologists for optimal management of individual patients.

Also available in print format.

Technical University of Mombasa
Tom Mboya Street, Tudor 90420-80100 , Mombasa Kenya
Tel: (254)41-2492222/3 Fax: 2490571